Understanding OR9H1P: A Potential Drug Target and Biomarker (G81439)

Target Name: OR9H1P

NCBI ID: G81439

OR9H1P

Other Name(s): Olfactory receptor, family 9, subfamily H, member 1 pseudogene | VNFT9373 | olfactory receptor family 9 subfamily H member 1 pseudogene | seven transmembrane helix receptor | UNQ9373

Understanding OR9H1P: A Potential Drug Target and Biomarker

Olfactory receptor, family 9, subfamily H, member 1 (OR9H1P) is a gene that encodes a protein known as the OR9H1P protein. OR9H1P is a member of the Olfactory receptor family, which is a large family of sensory receptors that play a crucial role in the sense of smell. OR9H1P is the pseudogene, which means that it is a genetic copy of a gene that does not have any functional RNA or protein products.

The OR9H1P gene was first identified in 2002 by researchers at the University of California, San Diego. The gene is located on chromosome 6, and it contains 251 amino acid residues. OR9H1P is located in the Olfactory receptor subfamily H, which consists of 15 genes that are responsible for the sense of smell.

OR9H1P is a putative drug target, which means that it is a potential target for drug development. The Olfactory receptor family has been identified as a potential drug target because of its role in the sense of smell. The sense of smell is a critical sense that allows humans to identify and remember different objects and scents. Drugs that can block the function of OR9H1P could potentially be used to treat various neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's disease, and depression.

Research on OR9H1P has been conducted primarily in the laboratory, and some researchers have used computer-aided design (CAD) software to predict the structure and function of the OR9H1P protein. OR9H1P has been shown to interact with several proteins, including the protein known as Transthyretin (TRETN). TRETN is a protein that is expressed in various tissues, including the brain, and it has been shown to be involved in the regulation of inflammation and fibrosis.

One of the challenges in studying OR9H1P is its high degree of genetic variation. OR9H1P has been shown to have a variable exon pattern, which means that different individuals may have different copies of the OR9H1P gene. This variable exon pattern can make it difficult to study the function of the gene because it is unclear what the OR9H1P protein does in different individuals.

Despite these challenges, researchers have been able to study the OR9H1P protein in various cell culture and animal models. OR9H1P has been shown to have a critical role in the development and maintenance of sensory systems, including the sense of smell. OR9H1P has also been shown to play a role in the regulation of pain and anxiety.

In addition to its potential drug target properties, OR9H1P has also been identified as a potential biomarker for various diseases. For example, OR9H1P has been shown to be expressed in the hypothalamus, which is a region of the brain that is involved in the regulation of body temperature. This suggests that OR9H1P may be a useful biomarker for the diagnosis and treatment of hypothermia. OR9H1P has also been shown to be expressed in the amygdala, which is a region of the brain that is involved in the regulation of fear and anxiety. This suggests that OR9H1P may be a useful biomarker for the diagnosis and treatment of anxiety and depression.

Overall, OR9H1P is a gene that has significant potential as a drug target and biomarker. Further research is needed to fully understand the function of OR9H1P and its potential clinical applications.

Protein Name: Olfactory Receptor Family 9 Subfamily H Member 1 Pseudogene

The "OR9H1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR9H1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets